Adoptive cell therapy using chimeric antigen receptor (CAR) technology is one of the most
advanced engineering platforms for cancer immunotherapy. CAR-T cells have shown …

Advancements in chimeric antigen receptor engineered T-cell (CAR-T) therapy have
revolutionized treatment for several cancer types over the past decade. Despite this success …

Natural killer (NK) cell therapies have emerged as a potential therapeutic approach to
various cancers. Their efficacy, however, is limited by their low persistence and anergy …

Abstract Treatment for renal cell carcinoma (RCC) has improved dramatically over the last
decade, shifting from high-dose cytokine therapy in combination with surgical resection of …

Acute myeloid leukemia (AML) is a heterogeneous disease developed from the malignant
expansion of myeloid precursor cells in the bone marrow and peripheral blood. The …

Background Pancreatic cancer, referred to as the “monarch of malignancies,” is a neoplastic
growth mostly arising from the epithelial cells of the pancreatic duct and acinar cells. This …

Natural killer (NK) cells are critical to the innate immune system, as they recognize antigens
without prior sensitization, and contribute to the control and clearance of viral infections and …

Natural killer (NK) cells are derived from hematopoietic stem cells. They belong to the innate
lymphoid cell family, which is an important part of innate immunity. This family plays a role in …

Natural killer (NK) cells are cellular components of the innate immune system that can
recognize and suppress the proliferation of cancer cells. NK cells can eliminate cancer cells …

Chimeric antigen receptor natural killer (CAR‐NK) cell therapy represents a potent approach
to suppressing tumor growth because it has simultaneously inherited the specificity of CAR …